Abstract

The NLRP3 inflammasome is a multimeric protein complex that initiates an inflammatory form of cell death and triggers the release of proinflammatory cytokines IL-1β and IL-18. The NLRP3 inflammasome has been implicated in a wide range of diseases, including Alzheimer’s disease, Prion diseases, type 2 diabetes, and some infectious diseases. It has been found that a variety of stimuli including danger-associated molecular patterns (DAMPs, such as silica and uric acid crystals) and pathogen-associated molecular patterns (PAMPs) can activate NLRP3 inflammasome, but the specific regulatory mechanisms of NLRP3 inflammasome activation remain unclear. Understanding the mechanisms of NLRP3 activation will enable the development of its specific inhibitors to treat NLRP3-related diseases. In this review, we summarize current understanding of the regulatory mechanisms of NLRP3 inflammasome activation as well as inhibitors that specifically and directly target NLRP3.

Details

Title
Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors
Author
Yang, Yang 1 ; Wang, Huanan 2 ; Kouadir Mohammed 3 ; Song Houhui 1 ; Shi Fushan 2 

 Zhejiang A&F University, College of Animal Science and Technology, Key Laboratory of Applied Technology on Green-Eco-Healthy Animal Husbandry of Zhejiang Province, Zhejiang Provincial Engineering Laboratory for Animal Health Inspection and Internet Technology, Lin’an, PR China (GRID:grid.443483.c) (ISNI:0000 0000 9152 7385) 
 Zhejiang University, Department of Veterinary Medicine, College of Animal Sciences, Hangzhou, PR China (GRID:grid.13402.34) (ISNI:0000 0004 1759 700X) 
 Trustchem Co., Ltd, Nanjing, PR China (GRID:grid.13402.34) 
Publication year
2019
Publication date
Feb 2019
Publisher
Springer Nature B.V.
e-ISSN
20414889
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2178970968
Copyright
This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.